Close Menu

NEW YORK – The American Association for Clinical Chemistry announced Wednesday it will collaborate with the US Centers for Disease Control and Prevention and the CDC Foundation to expand access to lipid testing in resource-limited countries.

Under the partnership, AACC and CDC will provide new state of the art point-of-care lipid testing devices to remote sites globally and then will train local personnel on the use of the machines. The organizations will work with national clinical chemistry societies in the area to place the instruments and train users.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by
Thermo Fisher Scientific

With COVID-19 vaccines rolling out, clinical labs and test developers are preparing for changes in both demand for testing and types of testing for SARS-CoV-2.

Sponsored by

Amid the COVID-19 pandemic, hospitals and intensive care units around the world have been overwhelmed by unprecedented levels of demand. 

Sponsored by
LGC SeraCare Life Sciences

As we pass the one-year anniversary of both the COVID-19 pandemic and the first Emergency Use Authorized SARS-CoV-2 PCR detection assays, there remains significant opportunity for clinical laboratories to advance testing and support improved patient management.